skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Biological And Medical Sciences remover assunto: Pharmacology. Drug Treatments remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)
Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)

FLAKER, Greg ; LOPES, Renato D ; VINEREANU, Dragos ; HUSTED, Steen ; HARJOLA, Veli Pekka ; ROSENQVIST, Marten ; ALEXANDER, John H ; GRANGER, Christopher B ; AL-KHATIB, Sana M ; HERMOSILLO, Antonio G ; HOHNLOSER, Stefan H ; TINGA, Brian ; JUN ZHU ; MOHAN, Puneet ; GARCIA, David ; BARTUNEK, Jozef

Journal of the American College of Cardiology, 2014-03, Vol.63 (11), p.1082-1087 [Periódico revisado por pares]

New York, NY: Elsevier

Texto completo disponível

Citações Citado por
2
High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

Hijazi, Ziad ; Siegbahn, Agneta ; Andersson, Ulrika ; Granger, Christopher B ; Alexander, John H ; Atar, Dan ; Gersh, Bernard J ; Mohan, Puneet ; Harjola, Veli-Pekka ; Horowitz, John ; Husted, Steen ; Hylek, Elaine M ; Lopes, Renato D ; McMurray, John J.V ; Wallentin, Lars

Circulation (New York, N.Y.), 2014-02, Vol.129 (6), p.625-634 [Periódico revisado por pares]

Hagerstown, MD: by the American College of Cardiology Foundation and the American Heart Association, Inc

Texto completo disponível

Citações Citado por
3
In Silico Prediction and Experimental Evaluation of Furanoheliangolide Sesquiterpene Lactones as Potent Agents against Trypanosoma brucei rhodesiense
In Silico Prediction and Experimental Evaluation of Furanoheliangolide Sesquiterpene Lactones as Potent Agents against Trypanosoma brucei rhodesiense
Material Type:
Artigo 		Adicionar ao Meu Espaço

In Silico Prediction and Experimental Evaluation of Furanoheliangolide Sesquiterpene Lactones as Potent Agents against Trypanosoma brucei rhodesiense

SCHMIDT, Thomas J ; DA COSTA, Fernando B ; LOPES, Norberto P ; KAISER, Marcel ; BRUN, Reto

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.325-332 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
4
High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin
High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin

Hijazi, Ziad, MD, PhD ; Wallentin, Lars, MD, PhD ; Siegbahn, Agneta, MD, PhD ; Andersson, Ulrika, MSc ; Alexander, John H., MD, MHS ; Atar, Dan, MD ; Gersh, Bernard J., MB, ChB, DPhil ; Hanna, Michael, MD ; Harjola, Veli Pekka, MD, PhD ; Horowitz, John D., MD, PhD ; Husted, Steen, MD, MSc ; Hylek, Elaine M., MD, MPH ; Lopes, Renato D., MD, PhD ; McMurray, John J.V., MD ; Granger, Christopher B., MD

Journal of the American College of Cardiology, 2014, Vol.63 (1), p.52-61 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil
Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil

Valente, J. ; Zuzarte, M. ; Gonçalves, M.J. ; Lopes, M.C. ; Cavaleiro, C. ; Salgueiro, L. ; Cruz, M.T.

Food and chemical toxicology, 2013-12, Vol.62, p.349-354 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
A population-based study on chronic pain and the use of opioids in Portugal
A population-based study on chronic pain and the use of opioids in Portugal
Material Type:
Artigo 		Adicionar ao Meu Espaço

A population-based study on chronic pain and the use of opioids in Portugal

Azevedo, Luís Filipe ; Costa-Pereira, Altamiro ; Mendonça, Liliane ; Dias, Cláudia Camila ; Castro-Lopes, José Manuel

Pain (Amsterdam), 2013-12, Vol.154 (12), p.2844-2852 [Periódico revisado por pares]

Philadelphia, PA: Elsevier B.V

Texto completo disponível

Citações Citado por
7
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy

van Diepen, Sean ; Newby, L. Kristin ; Lopes, Renato D ; Stebbins, Amanda ; Hasselblad, Vic ; James, Stefan ; Roe, Matthew T ; Ezekowitz, Justin A ; Moliterno, David J ; Neumann, Franz-Josef ; Reist, Craig ; Mahaffey, Kenneth W ; Hochman, Judith S ; Hamm, Christian W ; Armstrong, Paul W ; Granger, Christopher B ; Theroux, Pierre

International journal of cardiology, 2013-10, Vol.168 (3), p.2127-2133 [Periódico revisado por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
8
Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte species
Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte species
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte species

Pinto, E. ; Hrimpeng, K. ; Lopes, G. ; Vaz, S. ; Gonçalves, M. J. ; Cavaleiro, C. ; Salgueiro, L.

European journal of clinical microbiology & infectious diseases, 2013-10, Vol.32 (10), p.1311-1320 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
9
Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis
Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis

Lopes, L C ; Spencer, F A ; Neumann, I ; Ventresca, M ; Ebrahim, S ; Zhou, Q ; Bhatnaga, N ; Schulman, S ; Eikelboom, J ; Guyatt, G

Clinical pharmacology and therapeutics, 2013-09, Vol.94 (3), p.367-375 [Periódico revisado por pares]

Basingstoke: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
10
N-Terminal Pro―B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)
N-Terminal Pro―B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)
Material Type:
Artigo 		Adicionar ao Meu Espaço

N-Terminal Pro―B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)

HIJAZI, Ziad ; WALLENTIN, Lars ; HUBER, Kurt ; HYLEK, Elaine M ; LOPES, Renato D ; MCMURRAY, John J. V ; GRANGER, Christopher B ; SIEGBAHN, Agneta ; ANDERSSON, Ulrika ; CHRISTERSSON, Christina ; EZEKOWITZ, Justin ; GERSH, Bernard J ; HANNA, Michael ; HOHNLOSER, Stefan ; HOROWITZ, John

Journal of the American College of Cardiology, 2013-06, Vol.61 (22), p.2274-2284 [Periódico revisado por pares]

New York, NY: Elsevier

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (179)
  2. Revistas revisadas por pares (187)

Data de Publicação 

De até
Refinar
  1. Antes de1991  (9)
  2. 1991Até1996  (22)
  3. 1997Até2002  (58)
  4. 2003Até2009  (60)
  5. Após 2009  (51)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.